Navigation Links
University of Miami President Donna E. Shalala, Pennsylvania Gov. Edward G. Rendell: Nurse Practitioners Are Key to Obama Health Care Reform, Call for Increased Federal Funding for Innovative Nurse-Managed Health Care
Date:5/8/2009

Solution Already in Place: "Nurse-Managed Health Centers" Essential to Easing Health Care Crisis; Even as Doctor Shortage Worsens, Nurses Are Able to Triple Number of Patients Aided.

WASHINGTON, May 8 /PRNewswire-USNewswire/ -- Health care reform that focuses on fixing health insurance without dealing with the chronic and growing shortage of primary care physicians is likely to encounter "Massachusetts-style growing pains" unless nurse practitioners are fully involved in health care reform, according to University of Miami President and former Secretary of the U.S. Department of Health and Human Services (HHS) Secretary Donna E. Shalala, Pennsylvania Governor Edward G. Rendell, and other experts brought together today by the American Academy of Nursing (AAN) and its "Raise the Voice" (RTV) campaign.

Shalala, Rendell and the others agreed that "Nurse-Managed Health Centers" - an innovative delivery model for primary and preventive care, especially for low-income and vulnerable populations - will be a vital ingredient in any plan to increase the capacity of the nation's health care delivery system. The good news is that these nurse practitioner-led facilities are a "solution in plain sight" that already has been tested in Pennsylvania and 40 other states. Today, there already are over 250 Nurse-Managed Health Centers across the U.S. providing assistance to millions of Americans. It is estimated that these existing health centers could be expanded to reach over 20 million Americans, a significant number of the estimated 46 million Americans without health care insurance.

Experts have expressed great concern about the nation's supply of primary care physicians, and their ability to meet the needs of patients throughout the United States. The current downturn in the number of primary care physicians is likely to increase during the next 20 years, resulting in a shortage of as many as 44,00
'/>"/>

SOURCE American Academy of Nursing, Washington, D.C.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. University HealthSystem Consortium Selects Sodexo to Provide Food and Nutrition Services
2. Grand Canyon University Recognizes Nurses
3. Medical University of South Carolina Automates Grants Allocation Process with Lombardi Business Process Management Software
4. Ajou University Hospital Becomes First in Korea to Treat Using RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
5. Davis Vision, Visionworks, United Concordia Dental and Louisiana State University School of Dentistry Partner with Hands on New Orleans
6. Wayne State University and Childrens Hospital of Michigan Research Team Discover Chemical That Plays a Major Role in Pediatric Obsessive-Compulsive Disorder
7. University HealthSystem Consortium Launches Tactics for Tough Times Initiative to Help Members With Issues Such as Capacity and Medication Management
8. The Ohio State University, Cardinal Health, State of Ohio to Invest $10 Million to Advance Medical Imaging Industry
9. Cleveland Clinic, University Hospitals and MetroHealth Collaborate on Free Medical Clinic May 2-3
10. Hahnemann University Hospital Granted Surgical Fellowship Training Program for Pelvic Floor Disorders
11. InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...fe remains unclear, researchers say , , ... suggests that enzyme replacement therapy can make...bry disease, a rare illness that affects the kidne..., linked to the lack of an enzyme that helps metab...ecause it boosts the risk for a stroke, heart atta...
(Date:12/2/2009)...Y., Dec. 2 Researchers ...in blood cancer research at the annual American So...s December 4-8, 2009. ,, Throughout the ASH co...) experts, including Chief Medical Officer Barton ...nt Services Hildy Dillon, and Vice President, Rese...
(Date:12/2/2009)...y federal government ends nine months of obstructi...RNewswire-USNewswire/ -- More than 2,300 healthcar...ilities across Southern California will soon vote ...Healthcare Workers (NUHW). ,, A majority of the... but SEIU delayed the election by filing frivolous...
(Date:12/2/2009)...al congress of the European Association of Echocar...an Society of Cardiology, where techniques of non-... New case reports will be presented at this year,...the role of this new technology. , Now, with su...likely that non-invasive imaging will gain more im...
(Date:12/2/2009)...ional Race Series to increase awareness of prostat... importance of early detection , ..., women, families, friends and neighbors – a...ipate in the Rudolph Ramble 5K. The Rudolph Rambl... which was launched by the Prostate Conditions Ed...
Breaking Medicine News(10 mins):Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2Health News:Media alert: EUROECHO 2009 2Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4
... announced today that it has submitted a supplemen...and Drug Administration (FDA) for VYVANSE(TM) (lis...ention Deficit Hyperactivity Disorder (ADHD) in ad... Matthew Emmens, Shire Chief Executive Officer. "W...
...he abattoir, especially because it is afflicted wi... the mad cow disease that took a heavy toll of th...year-old Freisian bull to the slaughterhouse is bu... the Wales health authorities. The bull is sacred...
...an alert following a malaria epidemic that has cla...people. "Doctors and paramedics have been ...uding mobile units, fanning out to vulnerable area...the mosquito-borne disease. "Between Janua...
...the war veterans who have come back after combat i...to the exposure to chemicals and other harmful sub...regions that are closely linked to learning and me...an Academy of Neurology's 59th Annual Meeting in B...
...evere chest pain today are much less likely to die...r counterparts even a few years ago, according to... time that a study has shown a significant drop in...t hospitals increased their use of certain drugs, ...
...iled to improve symptoms of moderate to severe chr... large, multi-center trial. The results o... trial of infliximab were published in the first i...ial commenting on the research, the failure of the...
Other Medicine News:Health News:VYVANSE(TM) Drug for the Treatment of ADHD in Adults 2Health News:Shambu With Bovine TB Being Prevented from Slaughter 2Health News:Malaria Claims 25 Lives in Assam 2Health News:Gulf War Veterans Exhibit Memory Impairment 2Health News:Good News for Sufferers of Heart Attack, Chest Pain 2Health News:Good News for Sufferers of Heart Attack, Chest Pain 3Health News:Good News for Sufferers of Heart Attack, Chest Pain 4Health News:Anti-inflammatory Drug Fails to Improve COPD Symptoms 2
(Date:12/2/2009)...sreal, December 2 Cardio...g developer of advanced,cardiovascular surgery tec...of Directors approved a one-for-three forward stoc...to Cardio Vascular Medical Device shareholders. ,...he estimated date the stock,split will be payable ...
(Date:12/2/2009)...., Dec. 2 Roche (SIX: RO...ed States Food & Drug Administration (FDA) app...nucleic acid test, to screen source plasma in pool...test, called the cobas® TaqScreen MPX Test fo...e, in-vitro test for the simultaneous, direct dete...
(Date:12/2/2009)...VER, N.J., Dec. 2 Novartis announc...presentation on Tasigna® (nilotinib) 200 mg c...onstrate the strength of the company,s hematology ..., The new data, at the 51st American Society of He...light the company,s current therapies and investig...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Advance in bowel cancer test research 48298 1Discovery raises new doubts about dinosaur bird links 8763 1Discovery raises new doubts about dinosaur bird links 8763 2Discovery raises new doubts about dinosaur bird links 8763 3Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 1Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 2Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 3
... WIRE)--Apr 23, 2007 - Aeolus,Pharmaceuticals, Inc...by researchers at Loma Linda University Medical Ce...hyrin antioxidants, AEOL,10113, may play an import...y ionizing radiation., Radiation therapy is used a...py in the care and management of nearly all adult ...
...eight loss medication Xenical,(orlistat 120mg) sig...lar risk factors such as blood pressure, glycaemic... people with type,2 diabetes and hypertension, acc...an Congress on Obesity (ECO), Budapest,Hungary.(1...already established,for Xenical that demonstrates ...
Other Medicine Technology:Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 2Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6
...ual acuity system allows you access to the most po...s 10 different optotypes, crowding bars, random se...d characters. Random character sequencing eliminat...gle letter, single line and multiple line selectio...
...ght Probes provide the surgeon with an indirect il...e to be easily visualized through the laser micros...catter technique, the surgeon can enhance visualiz...ap edge folds, corneal flap striae and flap alignm...
...ual acuity system allows you access to the most po...s 10 different optotypes, crowding bars, random se...d characters. Random character sequencing eliminat...gle letter, single line and multiple line selectio...
...channel sleep diagnostic collection software. Sand...eep diagnostic collection software offers customiz...t recording or post recording. The scoring display...p events including current number of events, frequ...
Medicine Products: